The vendor said it plans to launch a pilot study in the U.S. in the fourth quarter if the FDA approves the IDE. C-Scan is an ingestible capsule-based system aimed at enabling preparation-free colorectal cancer screening, according to the firm.
Copyright © 2018 AuntMinnie.com